SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001638599-19-000580
Filing Date
2019-05-31
Accepted
2019-05-31 16:18:37
Documents
1
Period of Report
2019-04-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4_6100.html 4  
1 PRIMARY DOCUMENT doc4_6100.xml 4 3668
  Complete submission text file 0001638599-19-000580.txt   5238
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Issuer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IBIOPHARMA, INC. 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711
Business Address
GENERAL HILL (Ret) JAMES T. (Reporting) CIK: 0001441718 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35023 | Film No.: 19870703